Sutro Biopharma (STRO) Stock Price
Sutro Biopharma Price
Over the last 9 years Sutro Biopharma grew revenue by 0.1% annually, reaching 60.42 M USD. For Sutro Biopharma, the net margin of -316.3% is down versus -179.7% a few years ago. The consensus 12-month price target for Sutro Biopharma is 50.00 USD, about 242.5% above where the stock trades today. Of 20 analysts, 18 rate the stock a buy — an overall Buy consensus.
Sutro Biopharma stock price
Sutro Biopharma business model & stock analysis
Frequently asked questions about Sutro Biopharma
Analysts currently set an average price target of 51.00 USD for the Sutro Biopharma stock (median: 50.00 USD), implying +249.3 % versus the latest price. The consensus is based on 20 analyst ratings.
20 analysts currently rate the Sutro Biopharma stock: 18 recommend buying, 1 holding and 1 selling. For 2026, analysts expect Sutro Biopharma to generate revenue of 49.89 M USD and earnings per share of -7.97 USD.
Converted at the current exchange rate, the Sutro Biopharma share trades at 13.03 EUR (14.60 USD).
The Sutro Biopharma share (STRO) is listed on 4 stock exchanges, including: NASDAQ (STRO), Frankfurt (S09.F), München (S09.MU), Düsseldorf (S09.DU).
The expected revenue of Sutro Biopharma is 49.89 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Sutro Biopharma is -68.40 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sutro Biopharma is currently -1.83. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sutro Biopharma stock.
The price-to-sales ratio (P/S) of Sutro Biopharma is currently 2.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sutro Biopharma stock.
The Eulerpool Quality Score for Sutro Biopharma is 1/10.
The ISIN of Sutro Biopharma is US8693672011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Sutro Biopharma is A2N6SG. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Sutro Biopharma is STRO. The ticker symbol is used to trade Sutro Biopharma shares on the stock exchange.
Sutro Biopharma stock
Sutro Biopharma Peer Group
Sutro Biopharma Ticker
All fundamentals and in-depth analysis of Sutro Biopharma
Our stock analysis for Sutro Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sutro Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.